Celcuity (CELC) Competitors $70.15 +4.65 (+7.10%) As of 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELC vs. RDNT, BTSG, SHC, OPCH, WGS, PRVA, HTFL, VCYT, CON, and SGRYShould you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Privia Health Group (PRVA), Heartflow (HTFL), Veracyte (VCYT), Concentra Group Holdings Parent (CON), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Celcuity vs. Its Competitors RadNet BrightSpring Health Services Sotera Health Option Care Health GeneDx Privia Health Group Heartflow Veracyte Concentra Group Holdings Parent Surgery Partners RadNet (NASDAQ:RDNT) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership. Which has better earnings & valuation, RDNT or CELC? RadNet has higher revenue and earnings than Celcuity. RadNet is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRadNet$1.83B3.38$2.79M-$0.20-401.99CelcuityN/AN/A-$111.78M-$3.45-20.33 Do analysts rate RDNT or CELC? RadNet currently has a consensus price target of $76.80, indicating a potential downside of 4.47%. Celcuity has a consensus price target of $65.50, indicating a potential downside of 6.63%. Given RadNet's stronger consensus rating and higher possible upside, equities research analysts clearly believe RadNet is more favorable than Celcuity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RadNet 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 3 Strong Buy rating(s) 3.13Celcuity 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is RDNT or CELC more profitable? Celcuity has a net margin of 0.00% compared to RadNet's net margin of -0.78%. RadNet's return on equity of 2.41% beat Celcuity's return on equity.Company Net Margins Return on Equity Return on Assets RadNet-0.78% 2.41% 0.82% Celcuity N/A -150.07%-64.67% Does the media favor RDNT or CELC? In the previous week, Celcuity had 15 more articles in the media than RadNet. MarketBeat recorded 27 mentions for Celcuity and 12 mentions for RadNet. RadNet's average media sentiment score of 0.92 beat Celcuity's score of -0.11 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 8 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 1 Very Positive mention(s) 7 Positive mention(s) 9 Neutral mention(s) 5 Negative mention(s) 3 Very Negative mention(s) Neutral Which has more volatility and risk, RDNT or CELC? RadNet has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500. Do insiders & institutionals have more ownership in RDNT or CELC? 77.9% of RadNet shares are owned by institutional investors. Comparatively, 63.3% of Celcuity shares are owned by institutional investors. 5.6% of RadNet shares are owned by insiders. Comparatively, 15.8% of Celcuity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryRadNet beats Celcuity on 11 of the 16 factors compared between the two stocks. Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELC vs. The Competition Export to ExcelMetricCelcuityMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.97B$3.41B$6.22B$10.49BDividend YieldN/A2.27%5.74%4.88%P/E Ratio-20.3022.9428.6527.04Price / SalesN/A425.29550.76162.85Price / CashN/A46.4037.3861.65Price / Book22.5610.4112.316.43Net Income-$111.78M-$52.53M$3.33B$276.72M7 Day Performance40.22%-1.69%-1.74%-2.95%1 Month Performance33.64%9.45%4.72%-0.09%1 Year Performance329.05%11.28%61.14%29.93% Celcuity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELCCelcuity1.75 of 5 stars$70.15+7.1%$65.50-6.6%+306.1%$2.97BN/A-20.3040News CoverageAnalyst ForecastRDNTRadNet3.3853 of 5 stars$71.72+1.6%$76.80+7.1%+19.7%$5.43B$1.83B-358.5811,021News CoverageBTSGBrightSpring Health Services2.4341 of 5 stars$29.48+3.9%$30.50+3.5%+100.4%$5.02B$11.27B95.1035,000News CoverageEarnings ReportAnalyst ForecastSHCSotera Health2.495 of 5 stars$15.67+2.1%$17.20+9.8%+6.4%$4.36B$1.10B195.903,000News CoverageOPCHOption Care Health4.7748 of 5 stars$26.67-0.1%$35.11+31.7%-7.5%$4.33B$5.00B21.348,088Positive NewsWGSGeneDx2.9003 of 5 stars$120.87-0.7%$104.13-13.9%+109.3%$3.50B$305.45M2,417.401,200News CoverageUpcoming EarningsAnalyst ForecastPRVAPrivia Health Group3.0373 of 5 stars$24.14+0.2%$28.91+19.8%+46.8%$2.96B$1.74B219.471,140Positive NewsHTFLHeartflowN/A$33.22-0.7%$36.60+10.2%N/A$2.79BN/A0.00699News CoveragePositive NewsVCYTVeracyte3.9824 of 5 stars$34.09-2.0%$40.90+20.0%+9.0%$2.74B$445.76M103.31790Analyst ForecastCONConcentra Group Holdings Parent2.5613 of 5 stars$20.17-0.7%$27.75+37.6%-3.4%$2.60B$1.90B16.9511,250SGRYSurgery Partners3.7636 of 5 stars$19.79+0.3%$31.14+57.4%-33.9%$2.53B$3.11B-13.8415,000 Related Companies and Tools Related Companies RadNet Competitors BrightSpring Health Services Competitors Sotera Health Competitors Option Care Health Competitors GeneDx Competitors Privia Health Group Competitors Heartflow Competitors Veracyte Competitors Concentra Group Holdings Parent Competitors Surgery Partners Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELC) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTesla to LEAVE the car market?Elon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredWhat Wall Street Won’t Say Out LoudDiscover the 7 key indicators before everyone else doesAmerican Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump cannot stop this trainThe Nobel Committee just confirmed what free-market thinkers have long argued — that true wealth isn’t built t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
